VCA (NASDAQ:WOOF) has received a short term rating of buy from experts at Zacks with a rank of 2. The stock has been rated an average of 1.67 by 6 Brokerage Firm. 3 Wall Street Firms have rated the stock as a strong buys. 2 stock experts have also suggested a buy rating. 1 Brokerage Firms have advised hold.
Other Equity analysts have also commented on the company shares. CL King initiates coverage on VCA (NASDAQ:WOOF). According to the latest information available, the shares are now rated Buy by the analysts at the agency. The rating by the firm was issued on April 1, 2016.
VCA (NASDAQ:WOOF) shares are expected to touch $68.2 in the short term. This short term price target has been shared by 5 analysts. However, the standard deviation of short term price estimate has been valued at 9.12. The target price could hit $78 on the higher end and $56 on the lower end.
VCA (NASDAQ:WOOF) rose 1.23% or 0.82 points on Tuesday and made its way into the gainers of the day. After trading began at $66.79 the stock was seen hitting $67.78 as a peak level and $66.7 as the lowest level. The stock ended up at $67.35. The daily volume was measured at 1,426,377 shares. The 52-week high of the share price is $67.78 and the 52-week low is $44. The company has a market cap of $5,443 million.
Shares of VCA Inc. rose by 3.41% in the last five trading days and 4.24% for the last 4 weeks. VCA Inc. is up 18.93% in the last 3-month period. Year-to-Date the stock performance stands at 22.45%.
VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Companys animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Companys communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Companys network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.